Japan's MHLW to renew pharmaceutical industry vision 2007

12 June 2006

Japan's Ministry of Health, Labor and Welfare has started to draw up an action plan to implement the goals in the Ministry's Vision of the Pharmaceutical Industry established on August 30, 2002, from the fiscal year 2007. To this end, it held a newly-established panel meeting on "the promotion of the pharmaceutical industry policy," with the aim of developing a new version.

Although the MHLW has recently published a report on the progress of the implementation of the goals in an action plan, this will expire in the current fiscal year (Marketletter May 22 issue). Therefore, the Ministry plans to produce a new action plan by the end of the fiscal year ending March 2007. This will be done by listening to the views and opinions of stakeholders, including the pharmaceutical industry organizations and health care professional associations several times during 2006.

At a June 5 meeting in a MHLW conference room packed with the Ministry officials, industry-related people and reporters, reflecting a great deal of interest, each pharmaceutical industry organizations presented its evaluation on the implementation of the current action plan and their requests/propositions for the future vision.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight